RQx lands funding through hard work and luck

11/29/2012 | Xconomy

RQx Pharmaceuticals was born after researcher Floyd Romesberg and investor Court Turner happened to strike up a conversation in a local coffee shop. Romesberg is developing arylomycin to work against gram-negative and -positive bacteria, potentially leading to a new broad-spectrum antibiotic. Turner's company, Avalon Ventures, provided the first $1 million for Romesberg to start a new company, and Correlation Ventures has since joined as a venture investor.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC